MedTrace Logo

KT vs IASTM on Upper Trapezius Myofascial Trigger Points To Compare Effect of KT VS IASTM on Pain Intensity, Pain Pressure Threshold, Cervical Range of Motion and Functional Disability Level.

NCT06899685 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-28

No results posted yet for this study

Summary

This study would answer the following question: Is there a difference in the effects between IASTM and KT on pain intensity level, pain pressure threshold, cervical range of motion (ROM), functional disability level and satisfaction level in subjects with upper trapezius myofascial trigger points?

The aims of this study are:

1. To investigate the effect of KT and IASTM on pain intensity level in subjects with upper trapezius myofascial trigger points.
2. To investigate the effects of KT and IASTM on pain pressure threshold in subjects with upper trapezius myofascial trigger points.
3. To investigate the effects of KT and IASTM on cervical range of motion (ROM) in subjects with myofascial trigger points.
4. To investigate the effect of KT and IASTM on functional disability level in subjects with upper trapezius myofascial trigger points.
5. To investigate the effects of KT and IASTM on satisfaction level in subjects with myofascial trigger points.

Conditions

  • Myofacial Pain Syndromes

Interventions

OTHER

tradional physical therapy treatment

Instructions, hot backs, Deep transverse friction massage, passive \&self stretch, Neck isometric and Scapular retraction exercises

OTHER

KT

Kinesiotaping

DEVICE

IASTM

Instrument Assisted Soft Tissue Mobolization

Sponsors & Collaborators

  • Reham Sayed Mesaed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-09-01
Completion
2025-04-01
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06899685 on ClinicalTrials.gov